Contract Manufacturing

Contract Manufacturing
AVVA RUS JSC, a private Russian pharmaceutical company, invites international partners for cooperation in contract manufacturing
Certificates or compliance with EU GMP, ISO 9001, ISO 13485
1996 —
established
Annual production capacity:
  • 3+
    billion tablets and capsules
Total area:
  • 17956
    m2
Production capacity per year:
  • 200+
    million units sachets, suppositories and syrups
Warehouse area:
  • 2420
    m2
Number of employees:
  • 500+
    employees

The manufacturing site of AVVA RUS JSC is located at 53a Luganskaya St., Kirov, Russia, and includes:

Facility for manufacturing of penicillin-like β-lactam antibiotics

Capsules, powders, tablets, coated tablets
Facility for manufacturing of penicillin-like β-lactam antibiotics

Facility for manufacturing of generic drugs

  • Production areas for finished dosage forms, including tablets, coated tablets , dragées, granules, capsules, suppositories, syrups, and emulsions;
  • Production area for pellets, including pancreatine pellets;
  • Production area for finished dosage forms from hydrolyzed lignin, including the manufacturing of a substance and medicinal products based on hydrolyzed lignin
  • Facility for manufacturing of generic drugs
    In autumn 2017, the existing quality system and Good Manufacturing Practices at the AVVA RUS plant in Kirov were audited by European state auditors.

    In January 2018, AVVA RUS obtained a EU GMP certificate EU GMP certificate to manufacture medicines for human use, thereby confirming the highest quality standard of its products.

    The products manufactured at the AVVA RUS production site can be registered and supplied in the Russian Federation, CIS, Mongolia, EU and other countries, which are current members of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) (Portugal, Romania, Cyprus, Chile, Vietnam, etc.)
    Currently, AVVA RUS is dynamically involved in the implementation of Pharma 2020, a Russian state program.
    Contract Manufacturing

    AVVA RUS has been manufacturing products for more than 20 years

    AVVA RUS has been manufacturing products for more than 20 years, and its current portfolio includes about 50 efficient drugs, including both generics (Micrazim, Ecofuril, Ecofucin, Minoleksin, ecoantibiotics etc.) and original medicines developed by the company (Lactofiltrum and Filtrum).
    You can get more detailed information about our preparations here

    The company specializes in the following key areas:

    Gastroenterology
    Gastroenterology
    Pediatrics
    Pediatrics
    Cardiology
    Cardiology
    Neurology
    Neurology
    Allergology
    Allergology
    Infectious diseases
    Infectious diseases
    In 2015 AVVA RUS JSC was included into the list of entities with a substantial impact on the industrial sector in Russia by the corresponding act of the Russian Ministry of Industry and Trade.
    With its considerable experience in contract works and regulatory support, AVVA RUS JSC is interested in localizing the products of international developers and manufacturers at its facilities and invites potential partners to mutually beneficial high-quality cooperation, including localizing the manufacturing of penicillin-like β-lactam antibiotics.
    AVVA RUS has been manufacturing products for more than 20 years

    Why us

    We use and apply modern technology
    We use and apply modern technology
    We use modern technological equipment and provide a system of quality and product safety
    We use modern technological equipment and provide a system of quality and product safety
    We effectively use our intellectual potential and carry out knowledge management
    We effectively use our intellectual potential and carry out knowledge management
    We offer long-term mutually beneficial relationships to our partners
    We offer long-term mutually beneficial relationships to our partners

    Advantages for potential AVVA RUS partners:

    • Wide experience in Russian regulatory system
    • Wide production capacities
    • Status of drugs as medicinal products manufactured in the Russian Federation
    • Public procurement sales opportunities with state support for Russian manufacturers
    • Broad coverage of the national market, work with large distributors, presence in the pharmacy and inpatient sectors
    • Advisory services of qualified health specialists
    • Experience in the successful introduction of new brands to the Russian market and a highly professional marketing and sales staff
    • Expert knowledge of all major therapeutic areas, including gastroenterology, otolaryngology, dermatology, pediatrics, gynecology and more
    • Flexible approach to developing cooperation with partners

    Our partners

    Do you want to become our partner?

    To get a more detailed offer, please complete the feedback form and our specialists will contact you as soon as possible.